-
EP3984993
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3984993
| EP3984993 - USE OF AMINOTHIOL COMPOUNDS AS CEREBRAL NERVE OR HEART PROTECTIVE AGENT [Right-click to bookmark this link] | Status | Request for examination was made Status updated on 18.03.2022 Database last updated on 31.08.2024 | |
| Former | The international publication has been made Status updated on 18.12.2020 | Most recent event Tooltip | 02.04.2024 | New entry: Renewal fee paid | Applicant(s) | For all designated states Shanghai Kechow Pharma, Inc. Room 3M, No.780 Cailun Road Zhangjiang Hi-Tech Park Pudong Shanghai 201203 / CN | [2022/16] | Inventor(s) | 01 /
TIAN, Hongqi No.238 Baidi Road, Nankai District Tianjin 300192 / CN | 02 /
LIU, Yahong No.238 Baidi Road, Nankai District Tianjin 300192 / CN | [2022/16] | Representative(s) | Viering, Jentschura & Partner mbB Patent- und Rechtsanwälte Am Brauhaus 8 01099 Dresden / DE | [2022/16] | Application number, filing date | 20821703.4 | 13.06.2020 | [2022/16] | WO2020CN95998 | Priority number, date | WO2019CN91065 | 13.06.2019 Original published format: PCT/CN2019/091065 | [2022/16] | Filing language | ZH | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2020249120 | Date: | 17.12.2020 | Language: | ZH | [2020/51] | Type: | A1 Application with search report | No.: | EP3984993 | Date: | 20.04.2022 | Language: | EN | [2022/16] | Search report(s) | International search report - published on: | CN | 17.12.2020 | (Supplementary) European search report - dispatched on: | EP | 15.06.2023 | Classification | IPC: | C07C319/06, C07C321/04, C07C319/12, A61K31/16, A61P25/00, A61P9/00, A61K31/132, A61K45/06 | [2023/29] | CPC: |
C07C323/25 (EP,US);
C07D277/06 (EP,US);
A61K31/132 (EP);
A61K31/16 (EP);
A61K31/4164 (EP);
A61K31/426 (EP);
A61K45/06 (EP);
A61P25/00 (EP);
A61P39/00 (US);
A61P9/00 (EP);
A61P9/10 (US);
C07C323/41 (EP);
C07D233/02 (EP,US)
(-)
|
| Former IPC [2022/16] | C07C319/06, C07C321/04, C07C319/12, A61K31/16, A61P25/00, A61P9/00 | Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2022/16] | Title | German: | VERWENDUNG VON AMINOTHIOLVERBINDUNGEN ALS HIRNNERVEN- ODER HERZSCHUTZMITTEL | [2022/16] | English: | USE OF AMINOTHIOL COMPOUNDS AS CEREBRAL NERVE OR HEART PROTECTIVE AGENT | [2022/16] | French: | UTILISATION DE COMPOSÉS AMINOTHIOL EN TANT QU'AGENTS DE PROTECTION DES NERFS CÉRÉBRAUX OU DU COEUR | [2022/16] | Entry into regional phase | 13.12.2021 | Translation filed | 13.12.2021 | National basic fee paid | 13.12.2021 | Search fee paid | 13.12.2021 | Designation fee(s) paid | 13.12.2021 | Examination fee paid | Examination procedure | 13.12.2021 | Examination requested [2022/16] | 04.01.2024 | Amendment by applicant (claims and/or description) | Fees paid | Renewal fee | 25.05.2022 | Renewal fee patent year 03 | 25.05.2023 | Renewal fee patent year 04 | 31.03.2024 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [I]WO2010014953 (UNIV COLORADO REGENTS [US], et al) | International search | [Y]CN1283994 (US BIOSCIENCE [US]); | [A]CN1679488 (OREAL [FR]); | [Y]CN103772245 (INST RADIATION MEDICINE CHINESE ACADEMY MEDICAL SCIENCES); | [A]WO2017140754 (ADVANCED BIODESIGN [FR]); | [XY]WO2018041245 (INST OF RADIATION MEDICINE CHINESE ACAD OF MEDICAL SCIENCES [CN]); | by applicant | CN106432014 | WO2018041245 |